Aratana Therapeutics Reports Fourth Quarter And Full Year 2013 Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

KANSAS CITY, Kan., March 13, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. /quotes/zigman/14823409/delayed/quotes/nls/petx PETX -0.62% , a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals, today announced its fourth quarter and full year 2013 financial results.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC